advertisement

WGA Rescources

Sbardella D 15

Showing records 1 to 15 | Display all abstracts from Sbardella D

92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Oddone F
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
Quaranta L; Bruttini C
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Rossetti L; Parravano M
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
Micheletti E; Micheletti E; Konstas AGP
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Sbardella D; Sbardella D; Coletta M
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
Michelessi M; Oddone F
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Ziccardi L; Roberti G
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
Katsanos A
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Carnevale C
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
Sbardella D
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Carnevale C
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
Sbardella D
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Romano D
Pharmaceuticals (Basel, Switzerland) 2021; 14:
91978 Glaucoma and neuroinflammation: An overview
De Angelis G; Riva I
Survey of Ophthalmology 2021; 66: 693-713
92819 Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review
Manni G; Parisi V
Pharmaceuticals (Basel, Switzerland) 2021; 14:

Issue 22-1

Change Issue


advertisement

Topcon